Clinical Trials in Philadelphia

Showing 4861-4880 of 20,904 trials

Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment

NCT05231824

Project ReLearn is testing the efficacy and cost-effectiveness of an Artificial Intelligence system for optimizing weight loss coaching. Participants are randomized to a 1-year weekly gold standard behavioral weight loss remote (video) group treatment or the AI-optimized treatment, which is made up of a combination of remote group treatment, short video call and automated message. In the AI-optimized condition, the system monitors outcomes (via wireless scale, mobile phone app, and wristworn tracker) and, each week, assigns each participant the treatments they have responding to the best, within certain time constraints.

ObesityWeight Loss

Drexel University336 participantsStarted Mar 2022

Philadelphia, Pennsylvania, United States

RECRUITINGNA< 1 mile

Real-time fMRI for Insular Cortex Brain State-triggered Experience Sampling

NCT05855525

In a neuroimaging session, study participants will repeatedly and intermittently report the content of their ongoing, self-generated experiences based on an experience-sampling protocol in which self-report ratings will be triggered based on real-time analysis of the participant's current brain state. The protocol will be conducted while participants are undergoing MRI scanning.

Healthy

Drexel University60 participantsStarted Feb 2024

Philadelphia, Pennsylvania, United States

RECRUITING< 1 mile

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

NCT05059444

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and explore its value in a healthcare environment subject to cost containment.

Bladder CarcinomaUreter CarcinomaRenal Pelvis Carcinoma+13 more

Guardant Health, Inc.2,020 participantsStarted Sep 2021

Birmingham, Alabama, United States • Chandler, Arizona, United States • Hot Springs, Arkansas, United States +54 more locations

Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment

Real-time fMRI for Insular Cortex Brain State-triggered Experience Sampling

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Find Trials by Condition in Philadelphia

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1)

Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction

Study of JK07 in Patients With Chronic Heart Failure

ERG Components in Schizophrenia and Bipolar Disorder Type I

19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS)

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

A Study to Determine How BI 907828 (Brigimadlin) is Taken up in the Tumor (Phase 0) and to Determine the Highest Dose of BI 907828 (Brigimadlin) That Could be Tolerated (Phase 1a) in Combination With Radiation Therapy in People With a Brain Tumor Called Glioblastoma

Oral Contraceptive Pill (OCP) Pharmacogenomics

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis